The Director of the Cancer Outcomes Research Program at the University of North Carolina Lineberger Comprehensive Cancer Center and colleagues at the FDA have developed guidelines to help drug developers include meaningful pain endpoints when...
12/5/2013 3:25 PM EST
More than 22,000 inmates entering North Carolina prisons in 2008 and 2009 were tested for HIV, but only 20 new cases of HIV were found, in a study led by Dr. David Wohl of the University of North Carolina School of Medicine.
11/26/2013 11:00 AM EST
A new study finds that survivors of hematopoietic stem cell transplant, an aggressive treatment for blood cancers, benefited from a two-part peer support process the authors call expressive helping.
11/26/2013 10:00 AM EST
Adriana S. Beltran, from UNC School of Medicine, found that the protein Engrailed 1 is overexpressed in basal-like carcinomas, and she designed a chain of amino acids to shut down the protein and kill basal-like tumors in the lab.
11/25/2013 11:00 AM EST
A study of 2,519 Kenyan men conducted by researchers at the University of North Carolina revealed that infection with the human papillomavirus (HPV) was associated with a higher subsequent risk of infection with HIV, a precursor to AIDS.
11/22/2013 9:15 AM EST
The development of a probe to measure the body’s immune function could lead to more accurate, individualized doses for cancer patients prescribed nanoparticle-based drugs, according to research conducted at the University of North Carolina.
11/20/2013 9:25 AM EST
Women who are obese face an increased risk of developing an aggressive sub-type of breast cancer known as ‘basal-like’, according to research conducted at the University of North Carolina.
11/18/2013 10:00 AM EST
When celebrities battle cancer, their stories make headlines around the world. Whether announcing their prognosis, seeking treatment or losing their battle, celebrities faced with cancer have a profound impact on the public – one that leads to...
11/12/2013 11:40 AM EST
Experts Available to Discuss NEJM Editorial on Use of PARP Inhibitors in Triple-Negative Breast Cancer
In the editorial, the UNC researchers explain the excitement about this new class of drugs and the importance of this trial. They also highlight the reasons that caution as well as enthusiasm is warranted.
1/3/2011 2:50 PM EST
Dr. Darren DeWalt, author of a JAMA editorial being released early online this week, is available for media interviews.
11/29/2010 11:45 AM EST
UNC expert available to discuss latest development in search for AIDS vaccine.
9/24/2009 12:40 PM EDT
UNC brain surgeon Anand Germanwala, M.D. and ENT surgeon Adam Zanation, M.D., collaborated to develop through-the-nose approach to repair a patient's ruptured brain aneurysm.
8/26/2009 9:00 AM EDT
Pneumonic plague expert available for interview at UNC-Chapel Hill.
8/5/2009 5:00 PM EDT
UNC School of Medicine experts offer story ideas for back to school, including: sleep apnea and tonsils, kids with restless leg syndrome and returning to normal sleep habits; an STD reality check for teens; how to return to school with prescription...
8/4/2009 8:30 PM EDT
Two infectious disease experts at the University of North Carolina at Chapel Hill "“ Dr. David Weber and Dr. Myron Cohen -- are available to discuss swine flu.
4/27/2009 12:00 PM EDT
Lance Armstrong broke his collarbone today in a bike race in Spain. Two orthopaedic surgeons at the University of North Carolina at Chapel Hill are available to discuss how this type of injury can be treated and what the road to recovery for...
3/23/2009 3:45 PM EDT